Biogen | BIIB - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Amgen USD 6.22B 34M 2026-06
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
Incyte USD 112.54M 3.08M 2026-06
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sanofi EUR 24.12B 620M 2026-06
Sanofi EUR 23.5B 812M 2026-03
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
United Therapeutics USD 193.8M 15.5M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06